Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Susanne R. Hayman"'
Autor:
Amie Fonder, Angela Dispenzieri, Eli Muchtar, Wilson I. Gonsalves, Prashant Kapoor, Rahma Warsame, Shaji Kumar, Mustaqeem A. Siddiqui, Ronald S. Go, David Dingli, Yi L. Hwa, Miriam Hobbs, Taxiarchis Kourelis, Francis K. Buadi, Morie A. Gertz, Martha Q. Lacy, Susanne R. Hayman, S. Vincent Rajkumar, Nelson Leung
Publikováno v:
European Journal of Haematology. 106:433-436
Autor:
Eli Muchtar, Susanne R. Hayman, David Dingli, Morie A. Gertz, Amie Fonder, Shaji Kumar, Steve R. Zeldenrust, Stephen J. Russell, Angela Dispenzieri, Francis K. Buadi, Rahma Warsame, Nelson Leung, Miriam Hobbs, Prashant Kapoor, Taxiarchis Kourelis, Martha Q. Lacy, Ronald S. Go, S. Vincent Rajkumar, Wilson I. Gonsalves, Yi L. Hwa, Robert A. Kyle
Publikováno v:
Leukemia. 33:1268-1272
It is well known that staging of patients with AL amyloidosis at diagnosis predicts for survival, but there is a paucity of literature delineating the prognostic value of these systems at relapse. We evaluated the prognostic value of AL staging among
Autor:
Yi L. Hwa, Shaji Kumar, Morie A. Gertz, Francis K. Buadi, Taxiarchis Kourelis, Ronald S. Go, Wilson I. Gonsalves, David Dingli, Prashant Kapoor, Angela Dispenzieri, Susanne R. Hayman, Steve R. Zeldenrust, Miriam Hobbs, Nelson Leung, Amie Fonder, Martha Q. Lacy, Stephen J. Russell, Rahma Warsame, S. Vincent Rajkumar
Publikováno v:
Blood. 130(13)
Among patients with immunoglobulin light chain (AL) amyloidosis, there is little consensus on when reinstitution of chemotherapy should occur. We conducted a retrospective study to evaluate the patterns of relapse or progression (R/P) and the timing
Publikováno v:
XIth International Symposium on Amyloidosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1781fac8fc23dd6542e5cde742c8bd1b
https://doi.org/10.1201/9781420043358.ch85
https://doi.org/10.1201/9781420043358.ch85
Autor:
David J. Inwards, Patrick B. Johnston, Martha Q. Lacy, Shaji Kumar, Ivana M. Micallef, Angela Dispenzieri, Stephen M. Ansell, Mark R. Litzow, Luis Poratta, Susanne R. Hayman, Dennis A. Gastineau, Morie A. Gertz, Michelle Elliot, William Hogan
Publikováno v:
Biology of Blood and Marrow Transplantation. 12(2)
Background: High dose therapy with autologous stem cell rescue has been shown to prolong survival in patients with multiple myeloma in randomized controlled trials. However, most of the prospective studies have included younger patients, usually 65 o